SCHEMBL17317704

SCHEMBL17317704

COc1cccc(OC)c1-c1cc(C(=O)NC(CC(=O)O)CC(C)C)nn1CC(C)C

nearest known ligand 0.73

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ APLNR P35414 20/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17326410 1.00 APLNR (0.73) APLNR
SCHEMBL17929216 1.00 APLNR (0.73) APLNR
Trifluoroacetic Acid SCHEMBL28455205 0.95 APLNR (0.69) APLNR
SCHEMBL17326402 0.93 APLNR (0.67) APLNR
SCHEMBL17326411 0.93 APLNR (0.67) APLNR
SCHEMBL17326765 0.92 APLNR (0.64) APLNR
SCHEMBL21468367 0.92 APLNR (0.64) APLNR
SCHEMBL21468145 0.92 APLNR (0.63) APLNR
SCHEMBL17326416 0.92 APLNR (0.63) APLNR
SCHEMBL17924703 0.91 APLNR (0.75) APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4021447-A1 METHODS AND USES FOR APELIN RECEPTOR AGONISTS Research Triangle Institute (US) 2022-07-06 — — EP claimed
WO-2021041791-A1 METHODS AND USES FOR APELIN RECEPTOR AGONISTS RTI INTERNATIONAL, INC. (US) 2021-03-04 — — WO claimed
US-10377718-B2 Apelin receptor (APJ) agonists and uses thereof RESEARCH TRIANGLE INSTITUTE (US) 2019-08-13 — — US claimed
US-11401244-B2 Apelin receptor (APJ) agonists and uses thereof RESEARCH TRIANGLE INSTITUTE (US) 2022-08-02 — — US disclosed
EP-4021447-A1 METHODS AND USES FOR APELIN RECEPTOR AGONISTS Research Triangle Institute (US) 2022-07-06 — — EP disclosed
WO-2021041791-A1 METHODS AND USES FOR APELIN RECEPTOR AGONISTS RTI INTERNATIONAL, INC. (US) 2021-03-04 — — WO disclosed
CN-106459004-B Apelin receptor (APJ) agonists and uses thereof 研究三角协会 2020-09-15 — — CN disclosed
US-20190315693-A1 APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF RES TRIANGLE INST (US) 2019-10-17 — — US disclosed
US-20190315693-A1 APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF RES TRIANGLE INST (US) 2019-10-17 — — US disclosed
US-10377718-B2 Apelin receptor (APJ) agonists and uses thereof RESEARCH TRIANGLE INSTITUTE (US) 2019-08-13 — — US disclosed
US-10377718-B2 Apelin receptor (APJ) agonists and uses thereof RESEARCH TRIANGLE INSTITUTE (US) 2019-08-13 — — US disclosed
EP-3152200-A1 APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF Research Triangle Institute (US) 2017-04-12 — — EP disclosed
US-20160207889-A1 APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF RESEARCH TRIANGLE INSTITUTE 2016-07-21 — — US disclosed
WO-2015188073-A1 APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF RESEARCH TRIANGLE INSTITUTE (US) 2015-12-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160207889-A1 APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF APLNR, AP1G1, APMAP APLNR 1/4885
US-11401244-B2 Apelin receptor (APJ) agonists and uses thereof APLNR, AP1G1, APMAP APLNR 1/4885
US-10377718-B2 Apelin receptor (APJ) agonists and uses thereof APLNR, AP1G1, APMAP APLNR 1/4885
US-20190315693-A1 APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF APLNR, AP1G1, APMAP APLNR 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback